Journey Strategic Wealth’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Buy |
35,695
+379
| +1% | +$1.1K | ﹤0.01% | 649 |
|
|
2025
Q1 | $75.9K | Buy |
35,316
+46
| +0.1% | +$99 | ﹤0.01% | 499 |
|
|
2024
Q4 | $136K | Sell |
35,270
-7
| -0% | -$27 | 0.01% | 486 |
|
|
2024
Q3 | $231K | Hold |
35,277
| – | – | 0.01% | 424 |
|
|
2024
Q2 | $256K | Buy |
35,277
+17
| +0% | +$123 | 0.01% | 296 |
|
|
2024
Q1 | $268K | Hold |
35,260
| – | – | 0.01% | 212 |
|
|
2023
Q4 | $160K | Hold |
35,260
| – | – | 0.01% | 213 |
|
|
2023
Q3 | $139K | Hold |
35,260
| – | – | 0.01% | 184 |
|
|
2023
Q2 | $110K | Buy |
+35,260
| New | +$110K | 0.01% | 187 |
|